FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123268199> ?p ?o ?g. }

• W2123268199 endingPage "86" @default.
• W2123268199 startingPage "167" @default.
• W2123268199 abstract "The novel benzoindane S 18126 possessed > 100-fold higher affinity at cloned, human (h) D4 (Ki = 2.4 nM) vs. hD2 (738 nM), hD3 (2840 nM), hD1 (> 3000 nM) and hD5 (> 3000 nM) receptors and about 50 other sites, except sigma1 receptors (1.6 nM). L 745,870 similarly showed selectivity for hD4 (2.5 nM) vs. hD2 (905 nM) and hD3 (> 3000 nM) receptors. In contrast, raclopride displayed low affinity at hD4 (> 3000 nM) vs. hD2 (1.1 nM) and hD3 receptors (1.4 nM). Stimulation of [35S]-GTPgammaS binding at hD4 receptors by dopamine (DA) was blocked by S 18126 and L 745,870 with Kb values of 2.2 and 1.0 nM, respectively, whereas raclopride (> 1000 nM) was inactive. In contrast, raclopride inhibited stimulation of [35S]-GTPgammaS binding at hD2 sites by DA with a Kb of 1.4 nM, whereas S 18126 (> 1000 nM) and L 745,870 (> 1000 nM) were inactive. As concerns presynaptic dopaminergic receptors, raclopride (0.01-0.05 mg/kg s.c. ) markedly enhanced DA synthesis in mesocortical, mesolimbic and nigrostriatal dopaminergic pathways. In contrast, even high doses (2. 5-40.0 mg/kg s.c.) of S 18126 and L 745,870 were only weakly active. Similarly, raclopride (0.016 mg/kg i.v.) abolished inhibition of the firing rate of ventrotegmental dopaminergic neurons by apomorphine, whereas even high doses (0.5 mg/kg i.v.) of S 18126 and L 745,870 were only weakly active. As regards postsynaptic dopaminergic receptors, raclopride potently (0.01-0.3 mg/kg s.c.) reduced rotation elicited by quinpirole in rats with unilateral lesions of the substantia nigra, antagonized induction of hypothermia by PD 128, 907, blocked amphetamine-induced hyperlocomotion and was effective in six further models of potential antipsychotic activity. In contrast, S 18126 and L 745,870 were only weakly active in these models (5.0-> 40.0 mg/kg s.c.). In six models of extrapyramidal and motor symptoms, such as induction of catalepsy, raclopride was likewise potently active (0.01-2.0 mg/kg s.c.) whereas S 18126 and L 745,870 were only weakly active (10.0-80.0 mg/kg s.c.). In freely moving rats, raclopride (0.16 mg/kg s.c.) increased levels of DA by + 55% in dialysates of the frontal cortex. However, it also increased levels of DA in the accumbens and striatum by 70% and 75%, respectively. In contrast to raclopride, at a dose of 0.16 mg/kg s.c. , neither S 18126 nor L 745,870 modified frontal cortex levels of DA. However, at a high dose (40.0 mg/kg s.c.), S 18126 increased dialysate levels of DA (+ 85%) and noradrenaline (+ 100%), but not serotonin (+ 10%), in frontal cortex without affecting DA levels in accumbens (+ 10%) and striatum (+ 10%). In conclusion, S 18126 and L 745,870 behave as potent and selective antagonists of cloned, hD4 vs. other dopaminergic receptor types in vitro. However, their in vivo effects at high doses probably reflect residual antagonist actions at D2 (or D3) receptors. Selective blockade of D4 receptors was thus associated neither with a modification of dopaminergic transmission nor with antipsychotic (antiproductive) or extrapyramidal properties. The functional effects of selective D4 receptor blockade remain to be established." @default.
• W2123268199 created "2016-06-24" @default.
• W2123268199 creator A5000682280 @default.
• W2123268199 creator A5007183018 @default.
• W2123268199 creator A5015680710 @default.
• W2123268199 creator A5019072094 @default.
• W2123268199 creator A5027797234 @default.
• W2123268199 creator A5029407655 @default.
• W2123268199 creator A5030049268 @default.
• W2123268199 creator A5039339834 @default.
• W2123268199 creator A5041494494 @default.
• W2123268199 creator A5045801598 @default.
• W2123268199 creator A5058418331 @default.
• W2123268199 creator A5090546204 @default.
• W2123268199 date "1998-10-01" @default.
• W2123268199 modified "2023-10-17" @default.
• W2123268199 title "S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride." @default.
• W2123268199 cites W14947124 @default.
• W2123268199 cites W1521506893 @default.
• W2123268199 cites W1526098691 @default.
• W2123268199 cites W1556416492 @default.
• W2123268199 cites W1556541082 @default.
• W2123268199 cites W1638544077 @default.
• W2123268199 cites W1664340875 @default.
• W2123268199 cites W1832727056 @default.
• W2123268199 cites W1852993176 @default.
• W2123268199 cites W1874438046 @default.
• W2123268199 cites W1895729847 @default.
• W2123268199 cites W1896218642 @default.
• W2123268199 cites W1911274800 @default.
• W2123268199 cites W1928587713 @default.
• W2123268199 cites W1951617736 @default.
• W2123268199 cites W1955765354 @default.
• W2123268199 cites W1966900917 @default.
• W2123268199 cites W1967181685 @default.
• W2123268199 cites W1968248600 @default.
• W2123268199 cites W1972744610 @default.
• W2123268199 cites W1972803223 @default.
• W2123268199 cites W1975977959 @default.
• W2123268199 cites W1979179687 @default.
• W2123268199 cites W1985321201 @default.
• W2123268199 cites W1985582613 @default.
• W2123268199 cites W1989507808 @default.
• W2123268199 cites W1990703741 @default.
• W2123268199 cites W1991255379 @default.
• W2123268199 cites W1992156446 @default.
• W2123268199 cites W1994224293 @default.
• W2123268199 cites W1999901204 @default.
• W2123268199 cites W2000508413 @default.
• W2123268199 cites W2002177958 @default.
• W2123268199 cites W2002505415 @default.
• W2123268199 cites W2002816540 @default.
• W2123268199 cites W2002855843 @default.
• W2123268199 cites W2007980582 @default.
• W2123268199 cites W2008170648 @default.
• W2123268199 cites W2010221886 @default.
• W2123268199 cites W2011033234 @default.
• W2123268199 cites W2012836570 @default.
• W2123268199 cites W2013460039 @default.
• W2123268199 cites W2013547715 @default.
• W2123268199 cites W2015650391 @default.
• W2123268199 cites W2016751178 @default.
• W2123268199 cites W2016851829 @default.
• W2123268199 cites W2018814167 @default.
• W2123268199 cites W2021729616 @default.
• W2123268199 cites W2025076170 @default.
• W2123268199 cites W2026692772 @default.
• W2123268199 cites W2026907501 @default.
• W2123268199 cites W2028432389 @default.
• W2123268199 cites W2028707761 @default.
• W2123268199 cites W2030121284 @default.
• W2123268199 cites W2033490388 @default.
• W2123268199 cites W2034967655 @default.
• W2123268199 cites W2036386823 @default.
• W2123268199 cites W2040083328 @default.
• W2123268199 cites W2047540295 @default.
• W2123268199 cites W2048174585 @default.
• W2123268199 cites W2048752288 @default.
• W2123268199 cites W2059230444 @default.
• W2123268199 cites W2060070131 @default.
• W2123268199 cites W2061359205 @default.
• W2123268199 cites W2064893949 @default.
• W2123268199 cites W2065295009 @default.
• W2123268199 cites W2067072499 @default.
• W2123268199 cites W2068026066 @default.
• W2123268199 cites W2070531627 @default.
• W2123268199 cites W2070639484 @default.
• W2123268199 cites W2070950079 @default.
• W2123268199 cites W2075028631 @default.
• W2123268199 cites W2078057335 @default.
• W2123268199 cites W2079683870 @default.
• W2123268199 cites W2081891621 @default.
• W2123268199 cites W2084919821 @default.
• W2123268199 cites W2085115684 @default.
• W2123268199 cites W2089718542 @default.
• W2123268199 cites W2090252372 @default.
• W2123268199 cites W2091129703 @default.
• W2123268199 cites W2094063039 @default.

• next